Hexastat

Known as: Rhône Poulenc Rorer Brand of Altretamine, Bellon Brand of Altretamine, Altretamine Bellon Brand 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1956-2017
010203019562016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
Previous chemotherapy trials in hormone refractory prostate cancer have resulted in low response rates and minimal survival… (More)
Is this relevant?
1999
1999
PURPOSE To evaluate the efficacy and toxicity of combination and sequential dose-dense chemotherapy with doxorubicin and… (More)
Is this relevant?
1999
1999
In a prospective multicenter trial, 279 patients with metastatic colorectal cancer who had failed 5-fluorouracil therapy were… (More)
Is this relevant?
1999
1999
Twenty-one patients with hormone refractory prostate cancer were enrolled to receive single-agent docetaxel (Taxotere; Rhône… (More)
Is this relevant?
1999
1999
Hormone-refractory prostate cancer is the terminal step in the natural history of prostate cancer. To date, no chemotherapeutic… (More)
Is this relevant?
1998
1998
PURPOSE Docetaxel and cisplatin has documented single-agent activity and different toxicity profiles in patients with metastatic… (More)
Is this relevant?
1998
1998
The combination in clinical trials of taxoids with doxorubicin has focused attention on possible drug interactions. One specific… (More)
Is this relevant?
1998
1998
PURPOSE Docetaxel (Taxotere, Rhone-Poulenc Rorer, Antony, France) and cisplatin are two of the most active single agents used in… (More)
Is this relevant?
1997
1997
 Docetaxel (Taxotere, Rhone-Poulenc Rorer) and etoposide are water-insoluble drugs formulated with polysorbate 80 for intravenous… (More)
  • figure 1
  • table 1
Is this relevant?
1995
1995
Docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) is a new taxoid currently being studied in phase II and III clinical… (More)
Is this relevant?